Xilia-Trio 1 Tablet SR: A Comprehensive Diabetes Management Solution

Xilia-Trio 1 Tablet SR is a unique combination medication specifically formulated to manage Type 2 diabetes. This carefully balanced formulation combines the following active ingredients:

* Glimepiride (1mg): Acts on the pancreas to stimulate insulin release, aiding blood glucose control.
* Metformin (500mg): A first-line therapy for Type 2 Diabetes, Metformin helps regulate blood sugar by lowering glucose production in the liver and enhancing insulin sensitivity.
* Voglibose (0.2mg): This drug acts as an alpha-glucosidase inhibitor, slowing down the breakdown of carbohydrates in the gut, helping to prevent rapid postprandial blood sugar spikes.

Xilia-Trio 1 Tablet SR is designed for once-daily administration and offers a streamlined approach to managing Type 2 Diabetes. The formulation combines effective, clinically proven medications to promote optimal blood glucose control, ensuring both individual and patient satisfaction.

This medication should only be taken under the guidance of a qualified medical professional.